Target intelligence / Profile preview

Bacterial DNA and nucleic acids (DNA/RNA)

Target
DNA/RNA
Molecular classification
Nucleic acid, Genetic material
01

Overview

Bacterial DNA and nucleic acids (RNA) are the essential molecules that store and transmit genetic information in prokaryotic organisms, serving as vital targets for various classes of antibiotics. These targets are characterized by unique structural and enzymatic features, such as circular DNA topology and specialized processing enzymes like DNA gyrase and bacterial RNA polymerase, which differ significantly from those in human cells [1.2.1, 1.4.5]. Antibacterial agents exploit these differences through mechanisms such as the inhibition of DNA supercoiling by fluoroquinolones, the blockade of transcription by rifamycins, and the direct chemical damage of DNA strands by nitroimidazoles [1.2.2, 1.4.1]. These drugs are indispensable for treating a wide array of bacterial infections, including tuberculosis and respiratory tract infections, although their use is complicated by the emergence of resistance mutations in target genes like gyrA and rpoB [1.3.3, 1.4.2]. Furthermore, potential cross-reactivity with human mitochondrial DNA and ribosomes necessitates careful monitoring for adverse effects such as tendon toxicity and neurological symptoms [1.4.3, 1.4.4].

Other names
Bacterial genomeBacterial genetic materialProkaryotic DNABacterial RNABacterial nucleic acid
02

Mechanism of action

Inhibition of DNA gyrase and topoisomerase IV, inhibition of DNA-dependent RNA polymerase, induction of DNA strand breaks via reactive intermediates, DNA intercalation, and inhibition of the RNA polymerase switch region.

03

Biological functions

Genetic information storageDNA replicationTranscriptionTranslationCell division
04

Disease associations

InfectionBacterial infectionSepsisTuberculosisUrinary tract infection
05

Safety considerations

Tendon rupture and tendonitisPeripheral neuropathyCentral nervous system effectsPhotosensitivityMitochondrial DNA damageClostridioides difficile-associated diarrheaQT interval prolongation
06

Interacting drugs

Ciprofloxacin

9 more in the full profile.

07

Biomarkers

Bacterial DNA load (qPCR)gyrA/gyrB mutationsrpoB mutationsparC/parE mutationsBacterial 16S rRNA sequencing

Beyond the preview

Go deeper on Bacterial DNA and nucleic acids (DNA/RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNA and nucleic acids (DNA/RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call